title: Dabigatran etexilate: a new oral thrombin inhibitor.
authors.affiliation: Department of Neurology, Royal Perth Hospital, 197 Wellington St, Perth, Australia 6001. gjhankey@cyllene.uwa.edu.au
authors.forename: Graeme J
authors.initials: GJ
authors.lastname: Hankey
authors.forename: John W
authors.initials: JW
authors.lastname: Eikelboom
mesh_terms: D000284:Administration, Oral; D000818:Animals; D000925:Anticoagulants / Q000008:administration & dosage / Q000493:pharmacokinetics; D058833:Antithrombin Proteins / Q000008:administration & dosage* / Q000493:pharmacokinetics; D001562:Benzimidazoles / Q000008:administration & dosage* / Q000493:pharmacokinetics; D000069604:Dabigatran; D006801:Humans; D011355:Prodrugs / Q000008:administration & dosage* / Q000493:pharmacokinetics; D011725:Pyridines / Q000008:administration & dosage* / Q000493:pharmacokinetics; D016032:Randomized Controlled Trials as Topic / Q000379:methods; D013917:Thrombin / Q000037:antagonists & inhibitors* / Q000378:metabolism; D054556:Venous Thromboembolism / Q000188:drug therapy / Q000378:metabolism
chemical_list: D000925:Anticoagulants; D058833:Antithrombin Proteins; D001562:Benzimidazoles; D011355:Prodrugs; D011725:Pyridines; D013917:Thrombin; D000069604:Dabigatran